- Medical Insurance Coverage for Diabetes Education
-
Kim K
- KMID: 2173854
- J Korean Diabetes.
- 2015 Dec;16(4):276-280.
- doi: 10.4093/jkd.2015.16.4.276
The high prevalence, mortality and medical cost in diabetes mellitus raise the issue of diabetes management as one of the important component of social well-being. Self-management education for type 2... -
- CITED
-
- Close
- SHARE
-
- Close
- Economic Evaluation of Diabetes Education
-
Noh JW, Kwon YD, Jung JH, Sim KH, Kim HS, Choi M, Park J
- KMID: 2173857
- J Korean Diabetes.
- 2015 Dec;16(4):293-302.
- doi: 10.4093/jkd.2015.16.4.293
BACKGROUND: Diabetes education, also known as diabetes self-management training or diabetes selfmanagement education, is effective in helping patients with diabetes control their illness and maximize their health. However, there is... -
- CITED
-
- Close
- SHARE
-
- Close
- Vaccination for Diabetic Patients: An Update
-
Yeom JS
- KMID: 2173849
- J Korean Diabetes.
- 2015 Dec;16(4):236-241.
- doi: 10.4093/jkd.2015.16.4.236
As Korean populations are getting older and the number of adults with diabetes is continually increasing, importance of prevention of infectious diseases through vaccination has increased. With recent introduction of... -
- CITED
-
- Close
- SHARE
-
- Close
- Resolution of Type 2 Diabetes Mellitus Following Interferon-alpha Therapy for Chronic Hepatitis C
-
Park HS, Kim YJ, Moon SY, Woo JY, Choi JK, Kim KU, Park JR, Son HY, Kim DM
- KMID: 2173860
- J Korean Diabetes.
- 2015 Dec;16(4):315-322.
- doi: 10.4093/jkd.2015.16.4.315
Hepatitis C virus (HCV) mainly affects the liver, but several tissues outside the liver have also been reported to be involved. It has been hypothesized that diabetes could be one... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Use of New Insulins and New Insulin Delivery Systems
-
Lim TS, Ko SH
- KMID: 2173850
- J Korean Diabetes.
- 2015 Dec;16(4):242-251.
- doi: 10.4093/jkd.2015.16.4.242
Insulin plays an important role in the treatment of diabetes. Since it was discovered in the early 1920s, major advances have been made in the medical use of insulin. However,... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Diabetic Ketoacidosis Induced by Sodium-Glucose Cotransporter 2 Inhibitor
-
Jun JH, Choe KJ, Woo YM, Park YR, Park YK, Kim WJ, Shim MS, Kim JY
- KMID: 2173859
- J Korean Diabetes.
- 2015 Dec;16(4):310-314.
- doi: 10.4093/jkd.2015.16.4.310
Sodium-glucose cotransporter 2 (SGLT2) inhibitors are a new class of oral antihyperglycemic drugs; inhibition of the cotransporter allows for increased renal glucose excretion that consequently leads to reduced plasma glucose... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Application of Glucagon-Like Peptide-1 Receptor Agonists
-
Min SH, Cho YM
- KMID: 2173851
- J Korean Diabetes.
- 2015 Dec;16(4):252-259.
- doi: 10.4093/jkd.2015.16.4.252
Glucagon-like peptide 1 (GLP-1) is an incretin hormone that is released from enteroendocrine L-cells upon nutrient absorption; it stimulates glucose-dependent insulin secretion from pancreatic betacells. GLP-1 has pleiotropic effects including... -
- CITED
-
- Close
- SHARE
-
- Close
- The Efficacy and Safety of Non-Nutritive Sweeteners
-
Ju DL
- KMID: 2173855
- J Korean Diabetes.
- 2015 Dec;16(4):281-286.
- doi: 10.4093/jkd.2015.16.4.281
High intake of added sugars increases the risk for obesity, type 2 diabetes, and cardiovascular disease. Non-nutritive sweeteners (NNS) are widely used in many beverages and food products to reduce... -
- CITED
-
- Close
- SHARE
-
- Close
- Recent Advances for Anti-Obesity Agents
-
Kim CS
- KMID: 2173852
- J Korean Diabetes.
- 2015 Dec;16(4):260-268.
- doi: 10.4093/jkd.2015.16.4.260
Obesity is one of the most significant risk factor for diabetes, cardiovascular disease, malignancy and other chronic diseases. The obesity and its associated conditions is one of the most urgent... -
- CITED
-
- Close
- SHARE
-
- Close
- How Digital Technology Will Contribute to Future Innovations in Healthcare
-
Choi YS
- KMID: 2173848
- J Korean Diabetes.
- 2015 Dec;16(4):231-235.
- doi: 10.4093/jkd.2015.16.4.231
Digital technology is dramatically transforming today's healthcare. Over the past decade, exponential advances in digital technology, especially in smart phones, have radically changed many aspects of everyday life. Medicine will... -
- CITED
-
- Close
- SHARE
-
- Close
- Narrative Therapy for Diabetic Patients
-
Koo MH
- KMID: 2173856
- J Korean Diabetes.
- 2015 Dec;16(4):287-292.
- doi: 10.4093/jkd.2015.16.4.287
Diabetic patients undergo psychosocial difficulties, including anger, because of their chronic disease, anxiousness of complications, and stress resulting from the need for self-management. These difficulties often lead to depression and... -
- CITED
-
- Close
- SHARE
-
- Close
- Update on the Pharmacologic Agents for Dyslipidemia
-
Lee SH
- KMID: 2173853
- J Korean Diabetes.
- 2015 Dec;16(4):269-275.
- doi: 10.4093/jkd.2015.16.4.269
Although statins have demonstrated consistent and strong effects on cardiovascular prevention, non-statin drugs have failed to show additional clinical benefit. Consequently, statins are currently recommended as first-line therapy in dyslipidemia.... -
- CITED
-
- Close
- SHARE
-
- Close
- The Effect of Vildagliptin on Visfatin in Korean Patients with Type 2 Diabetes: A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Prospective Study
-
Jang YH, In DH, Yang JK, Moon HJ, Yoon GT, Ryu AJ, Kim YJ, Lee EY, Kim HJ, Ku BJ, Lee JM, Park KS, Lee IS, Lee JM, Lim DM, Park KY, Kim SJ
- KMID: 2173858
- J Korean Diabetes.
- 2015 Dec;16(4):303-309.
- doi: 10.4093/jkd.2015.16.4.303
BACKGROUND: The effects of dipeptidyl peptidase-4 inhibitors on adipokines remain obscure. The aim of this study was to evaluate the effect of the addition of vildagliptin on visfatin, an adipokine... -
- CITED
-
- Close
- SHARE
-
- Close
